About the Emerging Biomarker Technologies Session
Emerging biomarker technologies are revolutionizing cancer diagnostics and treatment by offering more sensitive and specific tools for detecting tumors at an early stage. Biomarkers—such as proteins, genetic mutations, or molecules—serve as indicators of disease presence and progression. With advances in high-throughput screening and next-generation sequencing, scientists are discovering novel biomarkers that can predict cancer susceptibility, diagnose cancer earlier, and monitor treatment response. Liquid biopsy, a non-invasive test that detects tumor DNA or RNA in blood samples, is one such promising technology. These biomarkers enable clinicians to personalize treatments more effectively and offer a less invasive alternative to traditional biopsy procedures, ultimately improving patient outcomes and reducing treatment costs.
Topics Covered in Emerging Biomarker Technologies
Single-Cell Profiling
Spatial Transcriptomics
Mass Spectrometry Proteomics
Cell-Free DNA Assays
Multiplex Immunoassays
Volatile Organic Compounds
Related Scientific Sessions at CIOC 2027
Why Attend the Emerging Biomarker Technologies Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Emerging Biomarker Technologies work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Emerging Biomarker Technologies research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Emerging Biomarker Technologies track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Emerging Biomarker Technologies Conference 2027 — FAQs
What is the Emerging Biomarker Technologies track at CIOC 2027?
The Emerging Biomarker Technologies track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Emerging Biomarker Technologies. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Emerging Biomarker Technologies sessions?
Cancer researchers and clinicians, educators and students with an interest in Emerging Biomarker Technologies are all welcome — whether presenting or attending.
Can I present my research in the Emerging Biomarker Technologies track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Emerging Biomarker Technologies sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Emerging Biomarker Technologies track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.